Alphamab Oncology

Short Term Long Term Short Term Comparison Long Term Comparison
  • 9966
  • 1d-1.95%
  • 1w-2.59%
  • 1m-13.08%
  • 1y-73.22%
ATH
  • ATH Price$27.75
  • ATH Date2021-07-14
  • % since ATH-83.71%
  • % to ATH513.94%
ATL
  • ATL Price$3.86
  • ATL Date2024-02-05
  • % from ATL17.10%
  • Last Low Price$3.86
  • Last Low Date2024-02-05
  • % From Last Low17.10%
IPO
  • IPO Price$13.00
  • % Current ROI USD-65.23%
  • ATH Price$27.75
  • % ROI ATH 71,891.19%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="9966"]

Key Data [addtoany]

Current price $4.52
Sector Healthcare
Industry Biotechnology
Today's High/Low $4.6/$4.4
Volume 1,899,000.00
Previous Close $4.61
52 Week High/Low $16.98/$3.81
Market Cap 4,361,095,168.00
P/E Ratio 0
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $-0.22
Annualized Dividend $0
$4.52
[addtoany]
Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity